Elanco Animal Health (ELAN) Restructuring Costs (2017 - 2026)
Elanco Animal Health (ELAN) reported Restructuring Costs of $16.0 million for Q1 2026, up 77.78% on a YoY basis from $9.0 million in Q1 2025, and down 92.08% sequentially from $202.0 million in Q4 2025.
Elanco Animal Health (ELAN) Restructuring Costs (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Restructuring Costs data on file, last reported at $16.0 million in Q1 2026.
- For the quarter ending Q1 2026, Restructuring Costs rose 77.78% year-over-year to $16.0 million; the trailing twelve-month figure through Mar 2026 stood at $244.0 million (up 115.93% YoY), and the FY2025 full-year result was $237.0 million, up 58.0% from the prior year.
- Restructuring Costs slipped to $16.0 million in Q1 2026, from $202.0 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $202.0 million in Q4 2025 to a low of $1.0 million in Q2 2025.
- A 5-year average of $41.9 million and a median of $31.0 million in 2022 frame the typical range for Restructuring Costs.
- Peak annual rise in Restructuring Costs reached 2785.71% in 2025, while the deepest fall reached 98.75% in 2025.
- Tracing ELAN's Restructuring Costs over 5 years: stood at $31.0 million in 2022, then rose by 16.13% to $36.0 million in 2023, then tumbled by 80.56% to $7.0 million in 2024, then jumped by 2785.71% to $202.0 million in 2025, then sank by 92.08% to $16.0 million in 2026.
- Business Quant data shows ELAN's Restructuring Costs at $16.0 million in Q1 2026, $202.0 million in Q4 2025, and $25.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.00 Mn |
| Dec 31, 2025 | 202.00 Mn |
| Sep 30, 2025 | 25.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Sep 30, 2024 | 17.00 Mn |
| Jun 30, 2024 | 80.00 Mn |
| Mar 31, 2024 | 46.00 Mn |
| Dec 31, 2023 | 36.00 Mn |
| Sep 30, 2023 | 16.00 Mn |
| Jun 30, 2023 | 35.00 Mn |
| Mar 31, 2023 | 40.00 Mn |
| Dec 31, 2022 | 31.00 Mn |
| Sep 30, 2022 | 26.00 Mn |
| Jun 30, 2022 | 86.00 Mn |
| Mar 31, 2022 | 40.00 Mn |
| Dec 31, 2021 | 116.00 Mn |
| Sep 30, 2021 | 111.00 Mn |
| Jun 30, 2021 | 305.00 Mn |